Biotech - Press Releases

Date	Title	Company
28-Oct-2019	Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis	Arena Pharmaceuticals, Inc.
28-Oct-2019	Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment	Actinium Pharmaceuticals, Inc.
28-Oct-2019	Croma-Pharma GmbH Expands its Portfolio Introducing elure™	CROMA-PHARMA GmbH
28-Oct-2019	WuXi STA's Jinshan Facility Passes EMA Inspection	WuXi AppTec
26-Oct-2019	HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)	HistoIndex
26-Oct-2019	HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)	HistoIndex
26-Oct-2019	Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences	Adagene
25-Oct-2019	Mylan Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Alprazolam Tablets, USP C-IV 0.5 mg, Due to the Potential of Foreign Substance	Mylan N.V.
25-Oct-2019	Statement from Acting FDA Commissioner Ned Sharpless, M.D., on concerns with medical device availability due to certain sterilization facility closures	U.S. Food and Drug Administration
25-Oct-2019	Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek(TM) Prostate Cancer Study	Anixa Biosciences, Inc.
25-Oct-2019	Regeneron Colleagues Support 150 Community Organizations During Third Annual Day for Doing Good	Regeneron Pharmaceuticals, Inc.
25-Oct-2019	European Commission Approves Astellas' XOSPATA(TM) (gilteritinib) as a Monotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation	Astellas Pharma Inc.